Articles by Adeline Siew, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Adeline Siew, PhD

ABPI Sets Guidelines on Clinical Trial Disclosure

ABPI toolkit provides guidance to pharmaceutical companies on how to meet clinical trial transparency requirements
Aug 16, 2013

ABPI toolkit provides guidance to pharmaceutical companies on how to meet clinical trial transparency requirements

Rx-360 Advances Supply-Chain Security

Rx-360, a pharmaceutical industry supply-chain consortium, is advancing approaches between pharmaceutical companies, suppliers, and contract manufacturers to better secure the pharmaceutical supply chain.
Aug 1, 2013

Rx-360, a pharmaceutical industry supply-chain consortium, is advancing approaches between pharmaceutical companies, suppliers, and contract manufacturers to better secure the pharmaceutical supply chain.

Implications for APIs in the European Falsified Medicines Directive

Two industry groups offer perspectives on The European Falsified Medicines Directive.
Aug 1, 2013

Industry groups offered perspectives on the strengths and weaknesses of the European Falsified Medicines Directive.

Scientists Discover New Targets for Breast Cancer

Scientists at A*STAR's Genome Institute of Singapore (GIS) have identified genes that could be potential targets for anticancer agents in the treatment of aggressive breast cancer.
Jul 29, 2013

Scientists at A*STAR's Genome Institute of Singapore (GIS) have identified genes that could be potential targets for anticancer agents in the treatment of aggressive breast cancer.

Adaptimmune Initiates Phase I/IIa Clinical Trial in Ovarian Cancer

Adaptimmune has opened a Phase I/IIa ovarian cancer trial to evaluate its genetically engineered T cell treatment, with enhanced antitumor activity.
Jul 26, 2013

Adaptimmune has opened a Phase I/IIa ovarian cancer trial to evaluate its genetically engineered T cell treatment, with enhanced antitumor activity.

CPhI Pharma Insights: Formulation and Ingredients Report

The report highlights a need for greater third party certification to ensure GMP vigilance.
Jul 25, 2013

The report highlights a need for greater third party certification to ensure GMP vigilance.

Domino Introduces Fast-Drying Ink for High-Speed Coding

The new ink takes less a second to dry and is four times more fade resistant than inks that are typically used in retail packaging.
Jul 12, 2013

The new ink takes less a second to dry and is four times more fade resistant than inks that are typically used in retail packaging.

Molecular Profiles' New Site Receives MHRA Approval

The new production site is designed to handle a range of non-sterile dosage forms and allow for the manufacture of highly potent compounds.
Jul 12, 2013

Molecular Profiles has opened a new facility in the UK following official approval from MHRA.

Almac Adds Contained Drug Handling and Bottling Capabilities

Almac introduces handling and bottling capabilities in EU and US headquarters.
Jul 3, 2013

Almac introduces handling and bottling capabilities in EU and US headquarters.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here